Top > News Releases

Y's Therapeutics Appoints Takaharu Itoh as CFO on November 1, 2007


Takaharu Itoh (CFO)
1971     School of Business Administration, Kwansei Gakuin University
1971     Citibank
1988     Country Treasurer, Dow Chemical Company
             Board member, Mitsubishi Dow Chemical
1993     Executive Direcor(Development/Finance & Accounting, Human Resources &
             General Affairs), AMGEN
1995     Assistant to President & CFO, MILLIKEN
1998     Vice-President Finance & Administration, Pfizer Japan Inc.
2006     CFO & Senior Managing Director, CB Richard Ellis KK
2007     CFO, Y's Therapeutics Co., Ltd. (current position)

About Y's Therapeutics
Y's Therapeutics (http://www.ysthera.com) is a privately held biopharmaceutical company engaged in the R&D of novel therapeutics for the treatment of inflammation-mediated diseases, cancer, and other unmet medical needs. Y's focuses on the development of preclinical and early-stage clinical projects pursued through research collaborations and in-licensing opportunities from academic institutions and biotech companies. Y's is seeking collaborative relationships, including out-licensing of product rights and creation of joint ventures, for late-stage development, manufacturing and commercialization of its portfolio products. The company currently has several projects in its clinical and preclinical pipeline. Y's has operations in two locations, Y's Therapeutics Co., Ltd., of Tokyo, Japan, and Y's Therapeutics, Inc., of Burlingame, CA.

◈CONTACT◈
Kyoko Harigae
Administrations Department
Y's Therapeutics Co., Ltd.
+011-81-3-5784-2762
E-Mail：admin@ysthera.com

Top  |  Site Map  |  Access Map  |  Privacy Policy  |  Terms of Use